See the DrugPatentWatch profile for Adderall
Adderall is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy [1]. It is a central nervous system stimulant that helps improve focus and reduce impulsivity and hyperactivity [2]. The active ingredients in Adderall are amphetamine and dextroamphetamine [1].
How does Adderall work?
Adderall functions by increasing the levels of certain neurotransmitters in the brain, primarily dopamine and norepinephrine [3]. These chemicals play a role in attention, focus, and impulse control. By boosting their activity, Adderall helps individuals with ADHD manage their symptoms more effectively [2][3].
What are the different forms of Adderall?
Adderall is available in two formulations: immediate-release (IR) and extended-release (XR) [4]. Adderall IR is typically taken two to three times a day, while Adderall XR is taken once daily and designed to release medication gradually over several hours [4][5].
When does Adderall's patent exclusivity expire?
The original patents for Adderall have long since expired, allowing for the production of generic versions [6]. However, specific formulations or manufacturing processes might have additional patent protections that could extend exclusivity for those particular versions. For detailed patent timelines and expiration dates for specific Adderall products, consulting resources like DrugPatentWatch.com is recommended [7].
Who makes Adderall and its generic versions?
Takeda Pharmaceuticals, through its subsidiary Shire, is the manufacturer of brand-name Adderall [8]. Numerous pharmaceutical companies produce generic versions of amphetamine and dextroamphetamine, making these medications widely available [6].
What are the side effects of Adderall?
Common side effects of Adderall include decreased appetite, weight loss, dry mouth, difficulty sleeping, stomach pain, and increased heart rate [9]. More serious side effects can include cardiovascular problems, psychiatric issues like hallucinations or aggression, and growth suppression in children [9][10].
What are the risks associated with Adderall use?
Adderall carries a risk of misuse and addiction due to its stimulant properties [11]. It can also lead to serious cardiovascular events, particularly in individuals with pre-existing heart conditions [10]. Dependence can develop, and withdrawal symptoms may occur if the medication is stopped abruptly [11].
What are the alternatives to Adderall for ADHD?
Other stimulant medications, such as methylphenidate (e.g., Ritalin, Concerta), are common alternatives [12]. Non-stimulant medications like atomoxetine (Strattera), guanfacine (Intuniv), and clonidine (Kapvay) are also used [13]. Behavioral therapy and lifestyle changes are often recommended as complementary treatments [14].
How is Adderall regulated?
Adderall is classified as a Schedule II controlled substance by the U.S. Drug Enforcement Administration (DEA) due to its high potential for abuse and dependence [15]. This classification imposes strict regulations on its manufacturing, prescribing, and dispensing [15].
*
**Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022375s039,022376s036lbl.pdf
[2] https://www.nhs.uk/medicines/amphetamine-and-dextroamphetamine/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938271/
[4] https://www.rxlist.com/adderall-xr-vs-adderall-which-is-better-for-adhd/article.htm
[5] https://www.webmd.com/drugs/2/drug-5678/adderall-oral/details
[6] https://www.drugpatentwatch.com/
[7] https://www.drugpatentwatch.com/
[8] https://www.shire.com/
[9] https://www.mayoclinic.org/drugs-supplements/amphetamine-and-dextroamphetamine-oral-route/side-effects/dr-20064006
[10] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/adderall-and-adderall-xr-information
[11] https://www.dea.gov/factsheets/amphetamines
[12] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975602/
[13] https://www.uptodate.com/contents/treatment-of-attention-deficit-hyperactivity-disorder-in-children-and-adolescents-pharmacotherapy
[14] https://www.cdc.gov/ncbddd/adhd/treatment.html
[15] https://www.deadiversion.usdoj.gov/schedules/